ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE

ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE was reported 6296 times

ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMA SITE DERMATITIS 5 0.1515
1 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 38 0.0868
2 OBSTRUCTIVE DEFAECATION 5 0.0746
3 FAILURE OF CHILD RESISTANT PRODUCT CLOSURE 6 0.0435
4 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 5 0.0345
5 DUCHENNE MUSCULAR DYSTROPHY 3 0.0323
6 BURKHOLDERIA TEST POSITIVE 4 0.0323
7 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 211 0.0294
8 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 176 0.0259
9 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 149 0.0245
10 VAGINAL FLATULENCE 7 0.0231
11 ECZEMA INFANTILE 2 0.0208
12 CENTRAL NERVOUS SYSTEM STIMULATION 3 0.0169
13 SUSPECTED PRODUCT CONTAMINATION 14 0.0138
14 ANTICOAGULATION DRUG LEVEL ABNORMAL 2 0.0134
15 CONJUNCTIVAL SCAR 2 0.0132
16 POST-TUSSIVE VOMITING 2 0.0123
17 ACCIDENTAL OVERDOSE 368 0.0100
18 VAGAL NERVE STIMULATOR IMPLANTATION 3 0.0098
19 VESTIBULAR NEURONITIS 5 0.0094
20 BREATH HOLDING 3 0.0078
21 SHORT STATURE 2 0.0076
22 AUTOSCOPY 4 0.0074
23 STOMA SITE INFLAMMATION 5 0.0067
24 TRICHIASIS 2 0.0063
25 GASTROINTESTINAL MUCOSAL DISORDER 4 0.0061
26 OXYGEN SATURATION INCREASED 2 0.0059
27 FEELING DRUNK 41 0.0055
28 COMA HEPATIC 4 0.0054
29 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0054
30 NASAL TURBINATE HYPERTROPHY 2 0.0053
31 ACCIDENTAL DRUG INTAKE BY CHILD 8 0.0052
32 ADENOIDECTOMY 2 0.0052
33 STUBBORNNESS 2 0.0046
34 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
35 PRODUCT PACKAGING ISSUE 41 0.0043
36 GASTROINTESTINAL STOMA OUTPUT INCREASED 2 0.0043
37 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
38 FEMALE GENITAL TRACT FISTULA 7 0.0041
39 PRODUCT CONTAMINATION PHYSICAL 10 0.0039
40 CONTRAINDICATION TO MEDICAL TREATMENT 6 0.0039
41 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0039
42 MYDRIASIS 50 0.0039
43 ALVEOLITIS ALLERGIC 4 0.0039
44 INFANTILE SPITTING UP 2 0.0038
45 INAPPROPRIATE AFFECT 6 0.0038
46 PRESBYOPIA 2 0.0036
47 PRODUCT CLOSURE ISSUE 2 0.0036
48 STOMA SITE PAIN 5 0.0034
49 EXPIRED PRODUCT ADMINISTERED 112 0.0034
50 EUPHORIC MOOD 34 0.0033
51 PRODUCT OUTER PACKAGING ISSUE 3 0.0033
52 URETHRAL HAEMORRHAGE 2 0.0033
53 WRONG DRUG ADMINISTERED 29 0.0033
54 NEURITIS 5 0.0032
55 GASTROINTESTINAL STOMA COMPLICATION 5 0.0032
56 CEREBRAL PALSY 3 0.0032
57 PRODUCT LOT NUMBER ISSUE 7 0.0032
58 PRODUCT PACKAGE ASSOCIATED INJURY 7 0.0031
59 IMMUNE RECONSTITUTION SYNDROME 4 0.0031
60 SLOW RESPONSE TO STIMULI 4 0.0031
61 SLEEP TALKING 5 0.0029
62 STARING 7 0.0029
63 PRODUCT EXPIRATION DATE ISSUE 4 0.0029
64 VERTIGO POSITIONAL 5 0.0029
65 CATAPLEXY 4 0.0028
66 EYE ROLLING 2 0.0028
67 PSYCHOMOTOR HYPERACTIVITY 46 0.0028
68 RADICULOPATHY 7 0.0027
69 PRODUCT LABEL ISSUE 18 0.0027
70 MUSCLE DISCOMFORT 2 0.0025
71 PRODUCT DROPPER ISSUE 2 0.0025
72 CROUP INFECTIOUS 2 0.0025
73 UNDERWEIGHT 5 0.0025
74 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
75 PRODUCT TASTE ABNORMAL 34 0.0025
76 PROCTITIS 7 0.0025
77 REACTION TO PRESERVATIVES 2 0.0025
78 OTITIS EXTERNA 3 0.0025
79 SEIZURE CLUSTER 2 0.0024
80 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 3 0.0024
81 GASTROENTERITIS SALMONELLA 2 0.0024
82 WRONG PATIENT RECEIVED MEDICATION 6 0.0022
83 AUTISM SPECTRUM DISORDER 12 0.0022
84 NASAL DISCHARGE DISCOLOURATION 3 0.0022
85 DRUG ADMINISTRATION ERROR 66 0.0021
86 PSYCHOGENIC SEIZURE 2 0.0021
87 CHRONIC SINUSITIS 8 0.0021
88 OVERDOSE 450 0.0021
89 HYPERVIGILANCE 2 0.0021
90 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
91 PRODUCT DIFFICULT TO SWALLOW 2 0.0020
92 PRODUCT FORMULATION ISSUE 13 0.0020
93 PRODUCT SELECTION ERROR 2 0.0018
94 AORTIC DILATATION 2 0.0018
95 HEPATORENAL SYNDROME 3 0.0018
96 EXTRA DOSE ADMINISTERED 72 0.0018
97 INCORRECT DRUG ADMINISTRATION DURATION 48 0.0017
98 PRODUCT CONTAMINATION 6 0.0017
99 RETCHING 35 0.0016
100 ALLERGY TO CHEMICALS 2 0.0016
101 IATROGENIC INJURY 2 0.0016
102 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
103 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
104 COMPRESSION FRACTURE 8 0.0015
105 MACULAR HOLE 2 0.0015
106 EAR HAEMORRHAGE 3 0.0015
107 DRUG ABUSER 9 0.0015
108 REGURGITATION 5 0.0015
109 BILIARY TRACT DISORDER 2 0.0014
110 SCREAMING 9 0.0014
111 TRACHEOSTOMY 2 0.0014
112 HYPERTONIC BLADDER 4 0.0014
113 REACTION TO DRUG EXCIPIENTS 3 0.0014
114 GASTRIC BYPASS 3 0.0014
115 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 98 0.0014
116 BIPOLAR I DISORDER 3 0.0014
117 STRABISMUS 4 0.0014
118 GENERALISED ANXIETY DISORDER 2 0.0014
119 GROWTH RETARDATION 4 0.0014
120 NO ADVERSE EVENT 245 0.0014
121 KNEE DEFORMITY 2 0.0013
122 LICHENOID KERATOSIS 3 0.0013
123 INCORRECT PRODUCT ADMINISTRATION DURATION 28 0.0013
124 FAECES HARD 5 0.0013
125 PRODUCT CONTAINER ISSUE 11 0.0013
126 PHARYNGEAL PARAESTHESIA 2 0.0013
127 STREPTOCOCCAL INFECTION 7 0.0013
128 OESOPHAGEAL CANDIDIASIS 5 0.0013
129 STUPOR 4 0.0012
130 BREATH ODOUR 3 0.0012
131 SELF-MEDICATION 5 0.0012
132 HALLUCINATION 91 0.0012
133 WRONG PRODUCT ADMINISTERED 8 0.0012
134 ACUTE SINUSITIS 2 0.0012
135 RECALLED PRODUCT 2 0.0012
136 PUPIL FIXED 2 0.0012
137 OCULAR ICTERUS 5 0.0012
138 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
139 INFUSION SITE DISCHARGE 2 0.0011
140 SEASONAL ALLERGY 16 0.0011
141 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
142 VOCAL CORD PARALYSIS 2 0.0011
143 PRODUCT TAMPERING 2 0.0011
144 FACIAL BONES FRACTURE 4 0.0011
145 ABNORMAL BEHAVIOUR 44 0.0011
146 BEHAVIOUR DISORDER 6 0.0011
147 LIVER TRANSPLANT 4 0.0011
148 CONDUCTION DISORDER 2 0.0011
149 LUMBAR VERTEBRAL FRACTURE 5 0.0011
150 EAR INFECTION 29 0.0011
151 CHOKING SENSATION 6 0.0011
152 HYPERTENSIVE HEART DISEASE 2 0.0011
153 TRAUMATIC HAEMORRHAGE 2 0.0011
154 FACE INJURY 4 0.0011
155 GASTROENTERITIS VIRAL 19 0.0011
156 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
157 HYPOREFLEXIA 2 0.0010
158 HALLUCINATION, VISUAL 22 0.0010
159 PARAESTHESIA ORAL 15 0.0010
160 CONVERSION DISORDER 2 0.0010
161 TOOTH DISCOLOURATION 3 0.0010
162 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
163 DRUG ABUSE 83 0.0010
164 FEELING JITTERY 19 0.0010
165 DRUG INEFFECTIVE 1308 0.0010
166 FOAMING AT MOUTH 2 0.0010
167 THERAPEUTIC RESPONSE UNEXPECTED 44 0.0010
168 PRODUCT COLOUR ISSUE 5 0.0010
169 ANAL PRURITUS 2 0.0010
170 ACUTE HEPATIC FAILURE 13 0.0010
171 SLEEP TERROR 4 0.0009
172 PRODUCT COMPLAINT 24 0.0009
173 PRODUCT PHYSICAL ISSUE 19 0.0009
174 PNEUMONIA VIRAL 3 0.0009
175 CHEILITIS 5 0.0009
176 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
177 COUGH 251 0.0009
178 DRUG PRESCRIBING ERROR 17 0.0009
179 SOMNOLENCE 178 0.0009
180 DISORIENTATION 35 0.0009
181 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
182 EYE MOVEMENT DISORDER 6 0.0009
183 INFUSION SITE INFECTION 2 0.0009
184 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
185 DEFAECATION URGENCY 6 0.0009
186 HANGOVER 3 0.0009
187 INGROWING NAIL 2 0.0008
188 MYOPIA 2 0.0008
189 URINARY HESITATION 2 0.0008
190 OXYGEN CONSUMPTION INCREASED 2 0.0008
191 WEIGHT ABNORMAL 2 0.0008
192 SCLERODERMA 3 0.0008
193 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
194 ACCIDENTAL EXPOSURE TO PRODUCT 84 0.0008
195 SUFFOCATION FEELING 2 0.0008
196 HEPATIC NECROSIS 3 0.0008
197 HYPOAESTHESIA ORAL 12 0.0008
198 INFUSION SITE SWELLING 5 0.0008
199 EXPOSURE VIA INGESTION 2 0.0008
200 VAGINAL DISCHARGE 8 0.0008
201 DRY THROAT 8 0.0008
202 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 23 0.0008
203 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 159 0.0008
204 PRODUCT USE ISSUE 146 0.0008
205 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
206 POOR QUALITY DRUG ADMINISTERED 5 0.0008
207 CATHETER SITE PAIN 2 0.0008
208 FAILURE TO THRIVE 4 0.0008
209 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
210 PRODUCT ODOUR ABNORMAL 8 0.0008
211 SOMNAMBULISM 5 0.0008
212 BLOOD POTASSIUM ABNORMAL 2 0.0007
213 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
214 ABDOMINAL MASS 2 0.0007
215 SINUS CONGESTION 10 0.0007
216 EAR CONGESTION 2 0.0007
217 SPUTUM DISCOLOURED 7 0.0007
218 DIZZINESS 368 0.0007
219 BLOOD PHOSPHORUS INCREASED 2 0.0007
220 HICCUPS 6 0.0007
221 PLEURITIC PAIN 2 0.0007
222 DROOLING 5 0.0007
223 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
224 DYSARTHRIA 27 0.0007
225 CRYING 26 0.0007
226 HALLUCINATIONS, MIXED 3 0.0007
227 BRAIN FOG 11 0.0007
228 PRODUCT USE COMPLAINT 11 0.0007
229 HYPERSOMNIA 20 0.0007
230 LIP PAIN 2 0.0007
231 LETHARGY 40 0.0007
232 FEELING ABNORMAL 166 0.0007
233 INCORRECT DOSE ADMINISTERED 158 0.0007
234 VOMITING PROJECTILE 2 0.0007
235 HYPOTHERMIA 7 0.0007
236 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
237 HYPERVENTILATION 4 0.0007
238 ORAL CANDIDIASIS 9 0.0007
239 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
240 HEPATITIS FULMINANT 2 0.0007
241 IRON DEFICIENCY 3 0.0007
242 METABOLIC ENCEPHALOPATHY 2 0.0007
243 FREQUENT BOWEL MOVEMENTS 18 0.0007
244 DRUG EFFECT DELAYED 3 0.0007
245 VASCULAR DEVICE INFECTION 3 0.0007
246 VIRAL INFECTION 22 0.0007
247 EMERGENCY CARE 2 0.0007
248 INTENTIONAL OVERDOSE 42 0.0007
249 NERVOUSNESS 34 0.0007
250 DIASTOLIC DYSFUNCTION 2 0.0006
251 PHARYNGITIS STREPTOCOCCAL 7 0.0006
252 THROAT IRRITATION 29 0.0006
253 YELLOW SKIN 3 0.0006
254 FOREIGN BODY IN THROAT 2 0.0006
255 CUSHINGOID 2 0.0006
256 FINGER DEFORMITY 3 0.0006
257 INCOHERENT 4 0.0006
258 INSOMNIA 164 0.0006
259 POSTURE ABNORMAL 2 0.0006
260 BODY TEMPERATURE DECREASED 6 0.0006
261 INJECTION SITE INFECTION 2 0.0006
262 INFUSION SITE HAEMORRHAGE 2 0.0006
263 EXPOSURE DURING BREAST FEEDING 2 0.0006
264 APPETITE DISORDER 4 0.0006
265 HYPERNATRAEMIA 3 0.0006
266 VOMITING 283 0.0006
267 HEPATIC ENZYME ABNORMAL 3 0.0006
268 COAGULOPATHY 10 0.0006
269 FAECES DISCOLOURED 13 0.0006
270 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 107 0.0006
271 EYE SWELLING 22 0.0006
272 ATAXIA 7 0.0006
273 PRODUCTIVE COUGH 28 0.0006
274 MACULAR DEGENERATION 7 0.0006
275 PHOTOPHOBIA 11 0.0006
276 INITIAL INSOMNIA 6 0.0006
277 RESPIRATION ABNORMAL 4 0.0006
278 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
279 DRUG EFFECT INCOMPLETE 21 0.0006
280 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
281 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
282 WEIGHT FLUCTUATION 6 0.0006
283 LOGORRHOEA 2 0.0006
284 JOINT DISLOCATION 6 0.0006
285 COLD SWEAT 10 0.0006
286 RESPIRATORY TRACT CONGESTION 9 0.0006
287 NYSTAGMUS 3 0.0006
288 LUNG TRANSPLANT 2 0.0006
289 HEAD DISCOMFORT 10 0.0006
290 PRODUCT SUPPLY ISSUE 4 0.0006
291 FOOD POISONING 3 0.0006
292 FACIAL PAIN 5 0.0006
293 SINUS DISORDER 11 0.0006
294 DIARRHOEA 357 0.0006
295 ABDOMINAL PAIN UPPER 113 0.0005
296 RESTLESSNESS 20 0.0005
297 INCREASED TENDENCY TO BRUISE 5 0.0005
298 UNRESPONSIVE TO STIMULI 14 0.0005
299 HIATUS HERNIA 7 0.0005
300 LIP SWELLING 18 0.0005
301 DIPLOPIA 14 0.0005
302 HEART RATE ABNORMAL 3 0.0005
303 HYPERACUSIS 2 0.0005
304 IMPULSIVE BEHAVIOUR 2 0.0005
305 LACERATION 5 0.0005
306 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
307 GASTRIC INFECTION 2 0.0005
308 CLAVICLE FRACTURE 2 0.0005
309 PARANOIA 9 0.0005
310 DISSOCIATION 4 0.0005
311 PHARYNGEAL OEDEMA 8 0.0005
312 ATELECTASIS 5 0.0005
313 EYE DISORDER 17 0.0005
314 HEART RATE INCREASED 51 0.0005
315 PRODUCT LABEL CONFUSION 3 0.0005
316 PALLOR 14 0.0005
317 DYSSTASIA 15 0.0005
318 VITAMIN D DEFICIENCY 5 0.0005
319 ABDOMINAL WALL HAEMATOMA 1 0.0005
320 WOUND SECRETION 2 0.0005
321 ENERGY INCREASED 3 0.0005
322 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
323 ENURESIS 2 0.0005
324 RESTLESS LEGS SYNDROME 9 0.0005
325 PRODUCT USE IN UNAPPROVED INDICATION 122 0.0005
326 NIGHTMARE 17 0.0005
327 ABNORMAL FAECES 4 0.0005
328 CHROMATURIA 11 0.0005
329 SPINAL COMPRESSION FRACTURE 4 0.0005
330 THINKING ABNORMAL 9 0.0005
331 ABDOMINAL DISCOMFORT 81 0.0005
332 HYPOXIA 17 0.0005
333 THROAT TIGHTNESS 13 0.0005
334 NASAL DRYNESS 3 0.0005
335 PRODUCT QUALITY ISSUE 64 0.0005
336 CARDIAC FAILURE CHRONIC 2 0.0005
337 PURULENT DISCHARGE 2 0.0005
338 RASH GENERALISED 12 0.0005
339 RESPIRATORY TRACT INFECTION 12 0.0005
340 INTENTIONAL PRODUCT MISUSE 40 0.0005
341 HAEMORRHAGIC ANAEMIA 2 0.0005
342 EMOTIONAL DISORDER 14 0.0005
343 TREMOR 75 0.0005
344 RESPIRATORY RATE INCREASED 4 0.0005
345 WHEELCHAIR USER 2 0.0004
346 UNEVALUABLE EVENT 34 0.0004
347 SPINAL FRACTURE 9 0.0004
348 CHOLECYSTITIS CHRONIC 3 0.0004
349 CYANOSIS 7 0.0004
350 ANAL INCONTINENCE 4 0.0004
351 EYE INFECTION 5 0.0004
352 NASAL CONGESTION 26 0.0004
353 SEIZURE 51 0.0004
354 BODY TEMPERATURE INCREASED 9 0.0004
355 AGGRESSION 22 0.0004
356 EAR DISORDER 2 0.0004
357 URTICARIA 73 0.0004
358 MUSCLE TWITCHING 10 0.0004
359 SYNOVIAL CYST 2 0.0004
360 MENTAL STATUS CHANGES 12 0.0004
361 NEPHROGENIC ANAEMIA 2 0.0004
362 APHONIA 6 0.0004
363 ROSACEA 2 0.0004
364 BALANCE DISORDER 37 0.0004
365 ILLNESS 44 0.0004
366 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
367 MANIA 7 0.0004
368 SKIN TIGHTNESS 2 0.0004
369 AGITATION 31 0.0004
370 INTENTIONAL DOSE OMISSION 12 0.0004
371 CONVULSION 24 0.0004
372 SLEEP APNOEA SYNDROME 8 0.0004
373 INCREASED APPETITE 8 0.0004
374 FAECAL INCONTINENCE 2 0.0004
375 PANIC REACTION 3 0.0004
376 HUMERUS FRACTURE 2 0.0004
377 BLOOD PRESSURE INCREASED 63 0.0004
378 ADRENAL INSUFFICIENCY 5 0.0004
379 NOCTURIA 5 0.0004
380 SINUSITIS 42 0.0004
381 RENAL CELL CARCINOMA 2 0.0004
382 CONFUSIONAL STATE 66 0.0004
383 RENAL TUBULAR NECROSIS 4 0.0004
384 THERAPY CHANGE 4 0.0004
385 FLATULENCE 23 0.0004
386 HOSPICE CARE 4 0.0004
387 HYPERVOLAEMIA 2 0.0004
388 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
389 RHINORRHOEA 26 0.0004
390 SNEEZING 9 0.0004
391 HYDRONEPHROSIS 3 0.0004
392 VISION BLURRED 55 0.0004
393 HYPERAMMONAEMIA 2 0.0004
394 FLUID INTAKE REDUCED 2 0.0004
395 PRODUCT ADMINISTRATION ERROR 8 0.0004
396 DRUG TOLERANCE 2 0.0004
397 FEELING COLD 11 0.0004
398 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
399 DYSKINESIA 16 0.0004
400 PETIT MAL EPILEPSY 2 0.0004
401 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
402 HYPERSENSITIVITY 72 0.0004
403 ANKLE FRACTURE 6 0.0004
404 CONCUSSION 3 0.0004
405 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
406 EYE DISCHARGE 4 0.0004
407 PANIC ATTACK 14 0.0004
408 MULTIPLE ALLERGIES 3 0.0004
409 IRRITABILITY 23 0.0004
410 PARTIAL SEIZURES 2 0.0004
411 PULMONARY CONGESTION 5 0.0004
412 SARS-COV-2 TEST POSITIVE 5 0.0004
413 FURUNCLE 3 0.0004
414 PNEUMOTHORAX 6 0.0004
415 TRICUSPID VALVE INCOMPETENCE 3 0.0004
416 ADVERSE REACTION 5 0.0004
417 INFLUENZA 42 0.0004
418 RASH MACULAR 13 0.0004
419 FRUSTRATION TOLERANCE DECREASED 3 0.0004
420 STRESS FRACTURE 2 0.0004
421 ABDOMINAL RIGIDITY 1 0.0004
422 DECUBITUS ULCER 3 0.0004
423 BIPOLAR DISORDER 4 0.0004
424 ENCEPHALOPATHY 9 0.0004
425 JAW DISORDER 2 0.0004
426 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
427 ASTHENOPIA 2 0.0004
428 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
429 ERUCTATION 7 0.0004
430 DENTAL CARIES 4 0.0004
431 PROCEDURAL PAIN 10 0.0004
432 MEDICATION ERROR 20 0.0004
433 HAEMOPTYSIS 10 0.0004
434 MALNUTRITION 4 0.0004
435 SKIN INFECTION 4 0.0004
436 OCULAR DISCOMFORT 4 0.0004
437 INFUSION SITE ERYTHEMA 3 0.0004
438 SWOLLEN TONGUE 11 0.0004
439 HEPATIC ENZYME INCREASED 24 0.0004
440 IMPAIRED DRIVING ABILITY 4 0.0004
441 UPPER LIMB FRACTURE 7 0.0004
442 MOUTH SWELLING 2 0.0003
443 ANOSMIA 5 0.0003
444 SKIN WARM 2 0.0003
445 SYRINGE ISSUE 6 0.0003
446 APATHY 5 0.0003
447 UNDERDOSE 25 0.0003
448 HYPOVOLAEMIA 2 0.0003
449 HYPERHIDROSIS 44 0.0003
450 IMMUNOSUPPRESSION 3 0.0003
451 BRADYKINESIA 2 0.0003
452 URINARY INCONTINENCE 10 0.0003
453 SKIN HAEMORRHAGE 5 0.0003
454 PLEURISY 2 0.0003
455 NASOPHARYNGITIS 62 0.0003
456 PULMONARY HYPERTENSION 7 0.0003
457 LOSS OF CONSCIOUSNESS 43 0.0003
458 PYREXIA 116 0.0003
459 ANXIETY 95 0.0003
460 OROPHARYNGEAL DISCOMFORT 3 0.0003
461 TYPE 1 DIABETES MELLITUS 2 0.0003
462 TOOTHACHE 6 0.0003
463 TENSION 2 0.0003
464 VULVOVAGINAL BURNING SENSATION 2 0.0003
465 EYE PRURITUS 11 0.0003
466 INSURANCE ISSUE 5 0.0003
467 PNEUMONIA BACTERIAL 3 0.0003
468 DYSURIA 12 0.0003
469 ANGER 11 0.0003
470 BRONCHITIS 24 0.0003
471 PRODUCT DISTRIBUTION ISSUE 3 0.0003
472 DECREASED APPETITE 75 0.0003
473 DELUSION 5 0.0003
474 BACTERIAL INFECTION 6 0.0003
475 INFUSION SITE EXTRAVASATION 2 0.0003
476 PRE-EXISTING CONDITION IMPROVED 2 0.0003
477 DYSPNOEA EXERTIONAL 12 0.0003
478 POISONING 4 0.0003
479 BLOOD SODIUM DECREASED 6 0.0003
480 PALPITATIONS 37 0.0003
481 STEVENS-JOHNSON SYNDROME 7 0.0003
482 RASH MACULO-PAPULAR 7 0.0003
483 HEPATOTOXICITY 7 0.0003
484 HYPOPHAGIA 8 0.0003
485 SEROTONIN SYNDROME 6 0.0003
486 INFUSION SITE PAIN 4 0.0003
487 ANOREXIA 4 0.0003
488 FEELING HOT 19 0.0003
489 CARDIAC FLUTTER 2 0.0003
490 DYSTONIA 6 0.0003
491 HAEMATOCHEZIA 17 0.0003
492 AUTOIMMUNE DISORDER 3 0.0003
493 HEPATITIS ACUTE 2 0.0003
494 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
495 HEPATOMEGALY 3 0.0003
496 PRODUCT PREPARATION ISSUE 2 0.0003
497 ASPERGILLUS INFECTION 2 0.0003
498 INCORRECT PRODUCT STORAGE 4 0.0003
499 HYPOTONIA 3 0.0003
500 SKIN MASS 2 0.0003
501 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
502 QUALITY OF LIFE DECREASED 4 0.0003
503 GAIT DISTURBANCE 57 0.0003
504 FEAR 8 0.0003
505 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
506 POSTOPERATIVE WOUND INFECTION 2 0.0003
507 FEEDING DISORDER 6 0.0003
508 TASTE DISORDER 6 0.0003
509 VERTIGO 18 0.0003
510 EYELID PTOSIS 3 0.0003
511 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
512 SLUGGISHNESS 3 0.0003
513 HYPOAESTHESIA 44 0.0003
514 NAUSEA 231 0.0003
515 GASTRIC DISORDER 10 0.0003
516 PERIPHERAL COLDNESS 4 0.0003
517 JOINT EFFUSION 2 0.0003
518 SURGERY 17 0.0003
519 SYNCOPE 29 0.0003
520 ENCEPHALITIS 2 0.0003
521 HEADACHE 181 0.0003
522 LARGE INTESTINE PERFORATION 2 0.0003
523 FORMICATION 2 0.0003
524 HYPOMAGNESAEMIA 4 0.0003
525 MASS 4 0.0003
526 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
527 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
528 PAPULE 2 0.0003
529 BLINDNESS UNILATERAL 4 0.0003
530 MOOD SWINGS 9 0.0003
531 RETINAL HAEMORRHAGE 2 0.0003
532 FEAR OF INJECTION 2 0.0003
533 DISTURBANCE IN ATTENTION 15 0.0003
534 CONSTIPATION 60 0.0003
535 FAECES SOFT 2 0.0003
536 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
537 END STAGE RENAL DISEASE 5 0.0003
538 OFF LABEL USE 240 0.0003
539 ASPIRATION 3 0.0003
540 MAJOR DEPRESSION 2 0.0003
541 PNEUMONIA 88 0.0003
542 DRY MOUTH 22 0.0003
543 ARTHROPOD BITE 2 0.0003
544 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
545 SUNBURN 2 0.0003
546 SEDATION 7 0.0003
547 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
548 HEART RATE IRREGULAR 6 0.0003
549 COLITIS 10 0.0003
550 FOOT FRACTURE 5 0.0003
551 OSTEOPENIA 4 0.0003
552 CONDITION AGGRAVATED 80 0.0003
553 GASTRIC ULCER 5 0.0003
554 DEHYDRATION 35 0.0003
555 DISCOMFORT 16 0.0003
556 DRUG DISPENSING ERROR 4 0.0003
557 ACIDOSIS 2 0.0003
558 SWELLING FACE 17 0.0003
559 JAUNDICE 7 0.0003
560 BLOOD GLUCOSE INCREASED 49 0.0003
561 ACUTE RESPIRATORY FAILURE 5 0.0003
562 OROPHARYNGEAL PAIN 24 0.0003
563 FOOD ALLERGY 2 0.0003
564 MUSCULOSKELETAL CHEST PAIN 4 0.0003
565 DRUG SCREEN POSITIVE 2 0.0003
566 WHEEZING 15 0.0003
567 HEAD INJURY 8 0.0003
568 BACTERAEMIA 3 0.0003
569 NASAL DISCOMFORT 2 0.0003
570 DISEASE RECURRENCE 12 0.0003
571 HOT FLUSH 19 0.0003
572 RENAL CYST 2 0.0003
573 HALLUCINATION, AUDITORY 4 0.0003
574 BLOOD PRESSURE ABNORMAL 5 0.0003
575 ATRIAL FLUTTER 2 0.0003
576 BLOOD DISORDER 2 0.0002
577 CONTUSION 24 0.0002
578 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
579 MIOSIS 2 0.0002
580 OXYGEN SATURATION DECREASED 14 0.0002
581 NIGHT SWEATS 8 0.0002
582 SPEECH DISORDER 13 0.0002
583 PRESYNCOPE 6 0.0002
584 HYPERAESTHESIA 2 0.0002
585 ABASIA 6 0.0002
586 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
587 BURNING SENSATION 17 0.0002
588 DYSGEUSIA 18 0.0002
589 TOOTH EXTRACTION 3 0.0002
590 EPISTAXIS 18 0.0002
591 POLLAKIURIA 10 0.0002
592 SECRETION DISCHARGE 3 0.0002
593 TINNITUS 11 0.0002
594 DRUG USE DISORDER 2 0.0002
595 MUSCLE ATROPHY 3 0.0002
596 MALAISE 103 0.0002
597 SCAR 4 0.0002
598 RECTAL HAEMORRHAGE 10 0.0002
599 ANURIA 2 0.0002
600 POOR QUALITY SLEEP 5 0.0002
601 BLOOD MAGNESIUM DECREASED 2 0.0002
602 MUSCLE STRAIN 2 0.0002
603 HYSTERECTOMY 2 0.0002
604 AMNESIA 15 0.0002
605 DELIRIUM 8 0.0002
606 SKIN SWELLING 2 0.0002
607 PLATELET COUNT INCREASED 3 0.0002
608 URINE OUTPUT DECREASED 2 0.0002
609 BLOOD CALCIUM INCREASED 2 0.0002
610 GROIN PAIN 2 0.0002
611 IMMUNE SYSTEM DISORDER 3 0.0002
612 TOOTH INFECTION 3 0.0002
613 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
614 TRANSAMINASES INCREASED 5 0.0002
615 TOOTH DISORDER 5 0.0002
616 DYSPEPSIA 22 0.0002
617 THERAPY NON-RESPONDER 10 0.0002
618 DEVELOPMENTAL DELAY 2 0.0002
619 TACHYPNOEA 3 0.0002
620 DRUG TOXICITY 3 0.0002
621 IMPAIRED GASTRIC EMPTYING 3 0.0002
622 ABDOMINAL HERNIA 1 0.0002
623 MOVEMENT DISORDER 7 0.0002
624 RESPIRATORY ARREST 6 0.0002
625 RESPIRATORY DISTRESS 6 0.0002
626 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
627 ABNORMAL DREAMS 6 0.0002
628 COVID-19 38 0.0002
629 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
630 PERSONALITY CHANGE 2 0.0002
631 COORDINATION ABNORMAL 3 0.0002
632 MIDDLE INSOMNIA 4 0.0002
633 ERYTHEMA 44 0.0002
634 DIARRHOEA HAEMORRHAGIC 2 0.0002
635 ASTHENIA 80 0.0002
636 INTESTINAL OBSTRUCTION 8 0.0002
637 LEUKAEMIA 2 0.0002
638 ADVERSE DRUG REACTION 19 0.0002
639 SINUS TACHYCARDIA 3 0.0002
640 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
641 OCULAR HYPERAEMIA 10 0.0002
642 BRONCHOSPASM 3 0.0002
643 FUNGAL INFECTION 7 0.0002
644 AFFECT LABILITY 2 0.0002
645 PRESCRIBED OVERDOSE 4 0.0002
646 DIZZINESS POSTURAL 2 0.0002
647 EAR PAIN 4 0.0002
648 NEURALGIA 5 0.0002
649 DYSPHONIA 12 0.0002
650 CHEST DISCOMFORT 21 0.0002
651 CHOKING 4 0.0002
652 PHARYNGEAL SWELLING 2 0.0002
653 LIVER INJURY 5 0.0002
654 VITREOUS FLOATERS 2 0.0002
655 PSYCHOTIC DISORDER 6 0.0002
656 RASH 88 0.0002
657 VISUAL IMPAIRMENT 25 0.0002
658 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
659 IMMUNODEFICIENCY 3 0.0002
660 AGEUSIA 5 0.0002
661 PRURITUS 77 0.0002
662 PNEUMONIA ASPIRATION 5 0.0002
663 BRAIN INJURY 2 0.0002
664 HEPATIC FAILURE 6 0.0002
665 INTENTIONAL SELF-INJURY 4 0.0002
666 ARTHROPATHY 11 0.0002
667 BLOOD COUNT ABNORMAL 3 0.0002
668 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
669 TOOTH ABSCESS 2 0.0002
670 SKIN DISCOLOURATION 9 0.0002
671 HEPATITIS 5 0.0002
672 ATRIAL FIBRILLATION 19 0.0002
673 EAR DISCOMFORT 2 0.0002
674 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
675 RIB FRACTURE 4 0.0002
676 LIMB DISCOMFORT 6 0.0002
677 TEMPERATURE INTOLERANCE 2 0.0002
678 WEIGHT DECREASED 54 0.0002
679 VENTRICULAR EXTRASYSTOLES 2 0.0002
680 TENDERNESS 2 0.0002
681 MUSCLE SPASMS 35 0.0002
682 GASTRITIS 5 0.0002
683 MOUTH ULCERATION 4 0.0002
684 DERMATITIS ATOPIC 10 0.0002
685 SCRATCH 2 0.0002
686 INCONTINENCE 2 0.0002
687 CHEST PAIN 35 0.0002
688 FATIGUE 147 0.0002
689 OBESITY 3 0.0002
690 RASH ERYTHEMATOUS 9 0.0002
691 EATING DISORDER 4 0.0002
692 URINARY TRACT INFECTION 32 0.0002
693 WEIGHT INCREASED 42 0.0002
694 BREAST PAIN 2 0.0002
695 IMPAIRED WORK ABILITY 4 0.0002
696 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
697 PRURITUS GENERALISED 4 0.0002
698 SLEEP DISORDER 13 0.0002
699 HYPERTENSION 39 0.0002
700 SKIN LACERATION 2 0.0002
701 MOOD ALTERED 5 0.0002
702 OESOPHAGITIS 2 0.0002
703 MUSCULOSKELETAL STIFFNESS 16 0.0002
704 WOUND INFECTION 2 0.0002
705 INFUSION RELATED REACTION 12 0.0002
706 BLOOD PRESSURE DECREASED 12 0.0002
707 FOOT DEFORMITY 2 0.0002
708 PRODUCT DOSE OMISSION ISSUE 53 0.0002
709 DYSPNOEA 102 0.0002
710 GAIT INABILITY 6 0.0002
711 BLOOD UREA INCREASED 3 0.0002
712 DYSPHAGIA 17 0.0002
713 ORAL PAIN 4 0.0002
714 GASTROINTESTINAL DISORDER 16 0.0002
715 STATUS EPILEPTICUS 2 0.0002
716 MITRAL VALVE INCOMPETENCE 2 0.0002
717 ABDOMINAL PAIN 41 0.0002
718 MICTURITION URGENCY 2 0.0002
719 INTERNAL HAEMORRHAGE 2 0.0002
720 NEPHROLITHIASIS 8 0.0002
721 GASTRIC HAEMORRHAGE 2 0.0002
722 ELECTROLYTE IMBALANCE 2 0.0002
723 CHILLS 20 0.0002
724 SEXUAL DYSFUNCTION 2 0.0002
725 OSTEOPOROSIS 7 0.0002
726 MYOCLONUS 2 0.0002
727 ROAD TRAFFIC ACCIDENT 7 0.0002
728 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
729 BLOOD POTASSIUM DECREASED 5 0.0002
730 SKIN EXFOLIATION 14 0.0002
731 LEUKOCYTOSIS 3 0.0002
732 PARAESTHESIA 26 0.0002
733 BURSITIS 2 0.0002
734 HYPERGLYCAEMIA 6 0.0002
735 BONE DISORDER 3 0.0002
736 FIBROMYALGIA 4 0.0002
737 NO THERAPEUTIC RESPONSE 2 0.0002
738 RESPIRATORY DEPRESSION 2 0.0002
739 MUSCLE SPASTICITY 2 0.0002
740 PERIPHERAL SWELLING 25 0.0002
741 SEPSIS 18 0.0002
742 HEPATIC STEATOSIS 3 0.0002
743 NECK PAIN 9 0.0002
744 HAIR COLOUR CHANGES 2 0.0002
745 DRY EYE 8 0.0002
746 DRUG-INDUCED LIVER INJURY 5 0.0002
747 CELLULITIS 8 0.0002
748 FLUSHING 16 0.0002
749 INJURY 11 0.0002
750 LOWER LIMB FRACTURE 3 0.0002
751 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
752 ORAL HERPES 3 0.0002
753 KIDNEY INFECTION 3 0.0002
754 ECZEMA 8 0.0002
755 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
756 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
757 RESPIRATORY FAILURE 11 0.0002
758 FALL 50 0.0002
759 EYE HAEMORRHAGE 2 0.0001
760 URINARY RETENTION 5 0.0001
761 DEPRESSION 34 0.0001
762 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
763 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
764 TACHYCARDIA 13 0.0001
765 BLOOD GLUCOSE DECREASED 7 0.0001
766 EXPOSURE DURING PREGNANCY 9 0.0001
767 ANAPHYLACTIC REACTION 8 0.0001
768 ABDOMINAL DISTENSION 15 0.0001
769 HUNGER 2 0.0001
770 DERMATITIS 3 0.0001
771 PANCYTOPENIA 8 0.0001
772 SKIN REACTION 2 0.0001
773 JOINT SWELLING 17 0.0001
774 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
775 SUBDURAL HAEMATOMA 2 0.0001
776 PARALYSIS 2 0.0001
777 IMPAIRED QUALITY OF LIFE 2 0.0001
778 SWELLING 13 0.0001
779 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
780 DEVICE LEAKAGE 6 0.0001
781 PRODUCT DOSE OMISSION 9 0.0001
782 HYPOKINESIA 2 0.0001
783 PRODUCT DISPENSING ERROR 3 0.0001
784 PRODUCT PRESCRIBING ISSUE 3 0.0001
785 FLUID RETENTION 7 0.0001
786 LIVER FUNCTION TEST ABNORMAL 4 0.0001
787 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
788 HOSPITALISATION 21 0.0001
789 RENAL FAILURE 18 0.0001
790 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
791 HAEMORRHAGE INTRACRANIAL 2 0.0001
792 RESPIRATORY DISORDER 4 0.0001
793 PANCREATITIS 7 0.0001
794 LACRIMATION INCREASED 4 0.0001
795 DRUG INTERACTION 21 0.0001
796 MUSCULAR WEAKNESS 15 0.0001
797 STOMATITIS 8 0.0001
798 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
799 CHRONIC KIDNEY DISEASE 10 0.0001
800 INFECTION 19 0.0001
801 OEDEMA PERIPHERAL 16 0.0001
802 HIP ARTHROPLASTY 2 0.0001
803 ADVERSE EVENT 12 0.0001
804 HYPOTENSION 26 0.0001
805 BACK PAIN 30 0.0001
806 LUNG INFECTION 2 0.0001
807 EJECTION FRACTION DECREASED 2 0.0001
808 PRODUCT PRESCRIBING ERROR 3 0.0001
809 CYSTITIS 4 0.0001
810 ABSCESS 2 0.0001
811 MOBILITY DECREASED 9 0.0001
812 HYPOTHYROIDISM 4 0.0001
813 SENSORY DISTURBANCE 2 0.0001
814 DRUG INTOLERANCE 12 0.0001
815 LOCALISED INFECTION 3 0.0001
816 ASTHMA 14 0.0001
817 HYPOGLYCAEMIA 6 0.0001
818 BLOOD POTASSIUM INCREASED 2 0.0001
819 BACK DISORDER 2 0.0001
820 LUNG DISORDER 6 0.0001
821 PAIN 75 0.0001
822 PLATELET COUNT DECREASED 13 0.0001
823 VENTRICULAR TACHYCARDIA 2 0.0001
824 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
825 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
826 VISUAL ACUITY REDUCED 4 0.0001
827 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
828 SKIN DISORDER 4 0.0001
829 DRY SKIN 16 0.0001
830 CANDIDA INFECTION 2 0.0001
831 HAEMATEMESIS 3 0.0001
832 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
833 CIRCULATORY COLLAPSE 2 0.0001
834 ERECTILE DYSFUNCTION 3 0.0001
835 HYPOACUSIS 5 0.0001
836 HAEMATOMA 3 0.0001
837 MULTI-ORGAN FAILURE 2 0.0001
838 ILL-DEFINED DISORDER 7 0.0001
839 SEPTIC SHOCK 5 0.0001
840 MENTAL DISORDER 5 0.0001
841 LOCAL SWELLING 2 0.0001
842 MUSCULOSKELETAL PAIN 6 0.0001
843 ANHEDONIA 3 0.0001
844 NEUROTOXICITY 2 0.0001
845 AMENORRHOEA 2 0.0001
846 HEART RATE DECREASED 4 0.0001
847 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
848 ISCHAEMIC STROKE 2 0.0001
849 THIRST 2 0.0001
850 COLITIS ULCERATIVE 5 0.0001
851 PULMONARY OEDEMA 5 0.0001
852 DRUG EFFECT DECREASED 6 0.0001
853 LIMB INJURY 3 0.0001
854 PNEUMONITIS 3 0.0001
855 TREATMENT NONCOMPLIANCE 6 0.0001
856 BLOOD GLUCOSE ABNORMAL 2 0.0001
857 DIVERTICULITIS 3 0.0001
858 INJECTION SITE MASS 4 0.0001
859 CONJUNCTIVITIS 2 0.0001
860 WOUND 3 0.0001
861 THROMBOCYTOPENIA 12 0.0001
862 BLISTER 6 0.0001
863 EYE PAIN 6 0.0001
864 PAIN IN JAW 3 0.0001
865 BLOOD URINE PRESENT 2 0.0001
866 RED BLOOD CELL COUNT DECREASED 3 0.0001
867 EYE IRRITATION 6 0.0001
868 HAEMORRHOIDS 2 0.0001
869 SKIN FISSURES 2 0.0001
870 LABORATORY TEST ABNORMAL 3 0.0001
871 DISEASE PROGRESSION 12 0.0001
872 DISABILITY 2 0.0001
873 HAEMATOCRIT DECREASED 2 0.0001
874 PRESCRIBED UNDERDOSE 2 0.0001
875 CARDIAC FAILURE 8 0.0001
876 CARDIAC FAILURE CONGESTIVE 8 0.0001
877 APHASIA 3 0.0001
878 FULL BLOOD COUNT DECREASED 2 0.0001
879 EMOTIONAL DISTRESS 12 0.0001
880 CORONARY ARTERY DISEASE 3 0.0001
881 ARTHRALGIA 41 0.0001
882 PLEURAL EFFUSION 6 0.0001
883 PERITONITIS 2 0.0001
884 INTENTIONAL DRUG MISUSE 2 0.0001
885 TOXICITY TO VARIOUS AGENTS 16 0.0001
886 PULMONARY EMBOLISM 9 0.0001
887 MEMORY IMPAIRMENT 13 0.0001
888 METABOLIC ACIDOSIS 3 0.0001
889 IRRITABLE BOWEL SYNDROME 2 0.0001
890 LIVER FUNCTION TEST INCREASED 2 0.0001
891 SKIN CANCER 2 0.0001
892 OEDEMA 5 0.0001
893 APPLICATION SITE PAIN 2 0.0001
894 LIVER DISORDER 4 0.0001
895 ANAEMIA 17 0.0001
896 SHOCK 2 0.0001
897 HYPOKALAEMIA 4 0.0001
898 DEVICE USE ERROR 3 0.0001
899 HAEMORRHAGE 9 0.0001
900 RENAL DISORDER 4 0.0001
901 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
902 INFLUENZA LIKE ILLNESS 7 0.0001
903 NEUROPATHY PERIPHERAL 8 0.0001
904 CATARACT 5 0.0001
905 MIGRAINE 8 0.0001
906 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
907 MENTAL IMPAIRMENT 2 0.0001
908 MYALGIA 14 0.0001
909 LEUKOPENIA 4 0.0001
910 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
911 ACNE 6 0.0001
912 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
913 THERAPY CESSATION 4 0.0001
914 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
915 JOINT STIFFNESS 2 0.0001
916 DEPRESSED MOOD 4 0.0001
917 PAIN IN EXTREMITY 22 0.0001
918 PAIN OF SKIN 2 0.0001
919 BLOOD BILIRUBIN INCREASED 2 0.0001
920 RASH PRURITIC 4 0.0001
921 CARDIAC ARREST 6 0.0001
922 ACUTE KIDNEY INJURY 11 0.0001
923 RENAL FAILURE ACUTE 3 0.0001
924 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
925 THERAPY INTERRUPTED 5 0.0001
926 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
927 VAGINAL HAEMORRHAGE 3 0.0001
928 ACUTE MYOCARDIAL INFARCTION 2 0.0001
929 SUICIDE ATTEMPT 4 0.0001
930 SUICIDAL IDEATION 6 0.0001
931 EPILEPSY 2 0.0001
932 INJECTION SITE RASH 2 0.0001
933 FEMUR FRACTURE 2 0.0001
934 BLOOD CHOLESTEROL INCREASED 3 0.0001
935 COGNITIVE DISORDER 3 0.0001
936 NERVOUS SYSTEM DISORDER 2 0.0001
937 BONE DENSITY DECREASED 2 0.0001
938 ARTHRITIS 5 0.0001
939 ARRHYTHMIA 3 0.0001
940 MULTIPLE SCLEROSIS 3 0.0001
941 HIP FRACTURE 2 0.0001
942 LACTIC ACIDOSIS 2 0.0001
943 BLOOD CREATININE INCREASED 4 0.0001
944 CHOLELITHIASIS 2 0.0001
945 STAPHYLOCOCCAL INFECTION 2 0.0001
946 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
947 DEATH 52 0.0001
948 CEREBROVASCULAR ACCIDENT 10 0.0001
949 HAEMOGLOBIN DECREASED 6 0.0001
950 HAEMATURIA 2 0.0001
951 INFLAMMATION 3 0.0001
952 HYPERKALAEMIA 2 0.0001
953 INJECTION SITE ERYTHEMA 7 0.0001
954 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
955 ALOPECIA 11 0.0001
956 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
957 DEVICE ISSUE 5 0.0001
958 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
959 CARDIAC DISORDER 5 0.0001
960 HYPONATRAEMIA 3 0.0001
961 DIABETES MELLITUS 4 0.0001
962 HERPES ZOSTER 3 0.0001
963 INJECTION SITE SWELLING 4 0.0001
964 THROMBOSIS 4 0.0000
965 THERAPEUTIC RESPONSE DECREASED 3 0.0000
966 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
967 BLINDNESS 2 0.0000
968 OSTEOARTHRITIS 2 0.0000
969 DEEP VEIN THROMBOSIS 3 0.0000
970 PRODUCT STORAGE ERROR 4 0.0000
971 INJECTION SITE PAIN 14 0.0000
972 FEBRILE NEUTROPENIA 3 0.0000
973 ANGIOEDEMA 2 0.0000
974 NEOPLASM MALIGNANT 3 0.0000
975 NEUTROPENIA 6 0.0000
976 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
977 SKIN IRRITATION 2 0.0000
978 COMA 2 0.0000
979 COLORECTAL CANCER 2 0.0000
980 SKIN BURNING SENSATION 3 0.0000
981 INTERSTITIAL LUNG DISEASE 2 0.0000
982 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
983 PRODUCT SUBSTITUTION ISSUE 2 0.0000
984 DRUG DEPENDENCE 5 0.0000
985 INJECTION SITE REACTION 2 0.0000
986 MYOCARDIAL INFARCTION 5 0.0000
987 DEVICE MALFUNCTION 2 0.0000
988 DRUG DOSE OMISSION 4 0.0000
989 RENAL IMPAIRMENT 2 0.0000
990 MALIGNANT NEOPLASM PROGRESSION 2 0.0000